Search Results
May 05, 2026, 17:01 ET Norgine welcomes TGA registration in Australia of PEDMARQSI® (sodium thiosulfate anhydrous) for the prevention of cisplatin-induced hearing loss in children1
Australian Product Information, PEDMARQSI®: PEDMARQSI Product Information (PI). Accessed April 2026Brock PR, et al. N Engl J Med 2018; 378(25): 2376–2385Freyer DR, et al. Lancet Oncol 2017; 18(1): 63–74EMA. PEDMARQSI. Available at:
More news about: Norgine
May 05, 2026, 17:01 ET Norgine celebra el registro de la TGA en Australia de PEDMARQSI®
Australian Product Information, PEDMARQSI®: PEDMARQSI Product Information (PI). Consultado en abril de 2026Brock PR, et al. N Engl J Med 2018; 378(25): 2376–2385Freyer DR, et al. Lancet Oncol 2017; 18(1): 63–74EMA. PEDMARQSI. Disponible en:
More news about: Norgine
May 05, 2026, 17:01 ET Norgine se félicite de l'enregistrement par la TGA en Australie de PEDMARQSI® (thiosulfate de sodium anhydre) pour la prévention de la perte auditive induite par le cisplatine chez les enfants1
les produits australiens, PEDMARQSI®: PEDMARQSI Informations sur le produit (PI). Accédé en avril 2026Brock PR, et al. N Engl J Med 2018 ; 378(25) : 2376–2385Freyer DR, et al. Lancet Oncol 2017 ; 18(1) : 63–74EMA. PEDMARQSI. Disponible sur :
More news about: Norgine
May 05, 2026, 16:30 ET Ameren Announces First Quarter 2026 Results
outstanding in the first quarter of 2026."Customers depend on us every day for safe, reliable, and affordable energy—and demand is growing," said Martin J. Lyons, Jr., chairman, president and chief executive officer of Ameren Corporation. "Meeting these needs requires disciplined ongoing infrastructure investment.
More news about: Ameren Corporation
May 05, 2026, 16:15 ET EOG Resources Reports First Quarter 2026 Results
Total Operating Cost (GAAP) (including Total Exploration Costs (GAAP)) - (j)3,005
More news about: EOG Resources, Inc.
May 05, 2026, 16:05 ET QuidelOrtho Reports First Quarter 2026 Financial Results
preliminary revenue announcement and reflected a significantly weaker respiratory season and business disruption in China and the Middle East," said Brian J. Blaser, President and Chief Executive Officer of QuidelOrtho. "Importantly, we believe the underlying business remains strong and we are well positioned
More news about: QuidelOrtho Corporation
May 05, 2026, 12:15 ET Get Your Kicks With Route 66 Stamps
experience Route 66 for yourself along with the many historic and iconic landmarks you'll see along the way," Reid said.The stamps' photographer, David J. Schwartz, also spoke at the ceremony."Route 66 isn't history behind glass or a velvet rope. It's living history that people can still step into
More news about: U.S. Postal Service
May 05, 2026, 12:00 ET Dilworth Paxson Adds Three Attorneys to its Commercial Real Estate Group
YORK, May 5, 2026 /PRNewswire/ -- Dilworth Paxson LLP is pleased to announce that Robert L. Baker, Jr., Michael J. Willner, and Jesse M. Dimitro from Scarinci Hollenbeck LLC are joining the firm's Real Estate practice, further strengthening the firm's capabilities
More news about: Dilworth Paxson
May 05, 2026, 11:36 ET The Economic Calculus of GenAI Has Changed: Deterministic AI Is the New Imperative
www.quarrio.comReferencesApotheker, J., Beauchene, V., de Bellefonds, N., Forth, P., Franke, M. R., Grebe, M., Kataeva, N., Kirvelä, S., Kleine, D., de Laubier, R., Lukic, V., Luther, A., Martin, M., Walters, J., & Schweizer, C. (2025, September 30). The widening AI value
More news about: Quarrio
May 05, 2026, 11:21 ET The Latest Research Supports Massage Therapy for Muscle Recovery and Athletic Performance
[email protected] Citations:Arsovski D. Deep Tissue Massage Therapy: Effects on Muscle Recovery and Performance in Athletes. Int J Ther Massage Bodywork. 2025 Jun 12;18(2):40-51. doi: 10.3822/ijtmb.v18i2.1139. PMID: 40510040; PMCID: PMC12140169.Wei M,
More news about: American Massage Therapy Association
May 05, 2026, 11:08 ET Altura Expands Contract with The Michael J. Fox Foundation to Broaden Access to Parkinson's Research Opportunities
initiated a project to bring important Parkinson's and brain health studies to primary care and community health settings. The project, funded by The Michael J. Fox Foundation for Parkinson's Research (MJFF), has a goal to expand access to research,especially among historically underrepresented communities.
More news about: Altura
May 05, 2026, 10:06 ET Ellis Island Honors Society announces the 2026 Ellis Island Medals of Honor recipients
extraordinary group of individuals whose contributions have strengthened our nation and impacted communities around the world," said EIHS Chairman Nasser J. Kazeminy. "Representing a diverse range of fields, these honorees embody the enduring promise of a nation built on freedom and opportunity. The United
More news about: Ellis Island Honors Society
May 05, 2026, 09:28 ET AFSP Statement on the Importance of Antidepressants and Evidence-Based Treatment for Suicide Prevention
SSRIs. Am J Psychiatry. 2007;164(6):884-91. 3. Friedman R. Antidepressants' black-box warning – 10 years later. N Engl J Med. 2014; 371:1666-1668. 4. Mulder RT, Frampton CMA, Luty SE, Joyce PR. 18 months of drug treatment for depression: predicting relapse and recovery. J Affect Disord.
More news about: American Foundation for Suicide Prevention
May 05, 2026, 09:24 ET What's New in The Palm Beaches in 2026
Art – May 9-Nov. 1, 2026Cursed Images: Pictures Out of Context showcases 20th-century vernacular photographs from the Peter J. Cohen Collection, one of the largest privately held archives of anonymous photographs in the United States. The exhibition showcases anonymous snapshots
More news about: Discover The Palm Beaches
May 05, 2026, 09:00 ET Zifo's SiEE Boston Summit Charts New Roadmap for 'Practical AI' in Life Sciences, Bridging the Gap Between Business Vision and Lab Reality
Informatics Experience Exchange (SiEE) in Boston concluded with heavyweights from Sanofi, Takeda, AbbVie, Regeneron, Biogen, Eli Lilly, Novo Nordisk, J&J, and Broad Institute establishing that the industry's digital future now rests on the 'first mile' of lab data integrity.
More news about: Zifo Technologies
May 05, 2026, 09:00 ET Anchin to Host Third Annual Financial Services Forum on May 19 in New York City
www.anchin.com.For further information:Frank J. [email protected]
More news about: Anchin
May 05, 2026, 09:00 ET LABATON KELLER SUCHAROW LLP ANNOUNCES PROPOSED SETTLEMENT OF STOCKHOLDER CLASS ACTION INVOLVING TERRAFORM POWER, INC.
with prejudice.A hearing (the "Settlement Hearing") will be held on June 22, 2026 at 1:30 p.m., before The Honorable Kathaleen St. J. McCormick, Chancellor, either in person at the Court of Chancery of the State of Delaware, New Castle County, Leonard L. Williams Justice Center, 500
More news about: Labaton Keller Sucharow LLP
May 05, 2026, 08:05 ET Walbridge Is Building the Largest Project in Its 110-Year History -- Right Here in Michigan
trusted local trade partners:Motor City ElectricProgressive Mechanical Inc. (PMI)John E. GreenShaw / E-J ElectricSuperior Electric Great Lakes (SEGLC)Triangle ElectricUniversal Piping Industries (UPI)About WalbridgeWalbridge
More news about: Walbridge
May 05, 2026, 08:05 ET Johnson & Johnson study shows TREMFYA® (guselkumab) is the first and only IL-23 inhibitor to demonstrate efficacy in perianal fistulizing Crohn's disease
fistulizing Crohn's disease, a very difficult-to-treat and complex manifestation of this already challenging condition," said Ludovic de Beaucoudrey, PhD, J&J Innovative Medicine Vice President, Immunology, Global Medical Affairs, Gastroenterology and Autoantibody. "Building on decades of experience in immunology,
More news about: Johnson & Johnson
May 05, 2026, 08:05 ET Johnson & Johnson investigational co-antibody therapy JNJ-4804 shows potential to raise the bar for clinical efficacy in treating refractory inflammatory bowel disease
3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Fuzion Study (Abstract 1058b), Presented at Digestive Disease Week (DDW) May 2-5, 2026.6 Panés J, et al. Induction Combination Therapy with Guselkumab and Golimumab Followed by Guselkumab Monotherapy Maintenance: Results of the Phase 2a, Randomized,
More news about: Johnson & Johnson
May 05, 2026, 08:00 ET The Michael J. Fox Foundation Announces Landmark Parkinson's Study Enters New Era of Precision Medicine
www.michaeljfox.org/ppmi.About The Michael J. Fox Foundation for Parkinson's Research As the world's largest nonprofit funder of Parkinson's research, The Michael J. Fox Foundation is dedicated to accelerating a cure for Parkinson's disease and improved
More news about: The Michael J. Fox Foundation for Parkinson's Research
May 05, 2026, 08:00 ET Evernorth Announces Appointment of New Board Members and Senior Executives Ahead of Anticipated Public Listing
of an institutional investor to Evernorth as it builds a public-company treasury strategy for an emerging asset class. He has served as Principal at J Capital since 2009 and was previously Partner and Director of Research at Palo Alto Investors for more than a decade. He has more than 30 years of investing
More news about: Evernorth Holdings Inc.
May 05, 2026, 07:00 ET Harley-Davidson Announces "Back to the Bricks" Strategic Plan to Restore Performance and Deliver Profitable Growth
on terms that are acceptable to the Company and within its expectations; (i) successfully carry out its global manufacturing and assembly operations; (j) develop and introduce products, services and experiences on a timely basis that the market accepts, that enable the Company to generate desired sales
More news about: Harley-Davidson, Inc.
May 05, 2026, 07:00 ET Harley-Davidson Delivers First Quarter Financial Results
on terms that are acceptable to the Company and within its expectations; (i) successfully carry out its global manufacturing and assembly operations; (j) develop and introduce products, services and experiences on a timely basis that the market accepts, that enable the Company to generate desired sales
More news about: Harley-Davidson, Inc.
May 05, 2026, 06:45 ET Lilly's Omvoh (mirikizumab-mrkz) is the first and only IL-23p19 to demonstrate durable disease clearance in ulcerative colitis through four years
patients with moderately to severely active ulcerative colitis. Digestive Disease Week 2026. May 2-5, 2026. 2Andronic AM, et al. J Crohn's Colitis. 2023;17(Supplement_1):i529.
More news about: Eli Lilly and Company